Samsung NEXT Ventures

Samsung NEXT Ventures, established in 2013, is a venture capital arm of Samsung Electronics, headquartered in Mountain View, California. It focuses on investing in early-stage companies within the artificial intelligence, fintech, blockchain, health technology, infrastructure, and media technology sectors. The firm typically invests a minimum of USD 1 million, supporting innovative startups that align with Samsung's strategic growth opportunities.

Royi Benyossef

Investment Director

Sam Campbell

Investor

Carlos Castellanos

Investor

Andy Duong

Investment Director

Lizzy Goldman

Investor

Joan Kim

Investor

Emily Koster

Director of Communications

Amy Lee

Investor

Raymond Liao

Vice President | Ventures Managing Director

Yonatan Machado

Senior Investment Director

Jonathan Machado

Managing Director, Investment

Eyal Miller

Managing Director, General Manager, Israel

Nick Nigam

Principal, Seed to Series B Venture Capital Investments

Caroline Rehfuss

Investor

Past deals in Wellness

MiSalud Health

Series A in 2024
MiSalud is a health and wellness platform that focuses on delivering personalized preventative services and traditional healthcare tailored to the Latino community. The company provides a virtual care platform that connects users with Spanish-speaking physicians and experienced medical practitioners, ensuring culturally relevant care. Services offered include access to customized health plans, support groups, psychological support, and comprehensive wellness content in Spanish. MiSalud aims to enhance employee health and wellbeing while delivering measurable results for employers and employees alike, making healthcare more convenient and accessible.

Better Health

Series A in 2024
Better Health is a support and supplies platform designed to improve the management of chronic conditions such as ostomy, chronic wounds, diabetes, chronic retention, and incontinence through peer-to-peer connections. The platform offers expert guidance to help patients select and use the appropriate medical supplies while providing education and support to enhance engagement and adherence to treatment. This approach is endorsed by healthcare payers and providers, leading to better health outcomes, reduced overutilization of services, and improved mental health for users. Better Health operates across 48 states and collaborates with major payers, including Medicare, Medicaid, and several private insurers. The platform boasts a high customer satisfaction rating of 98%, reflecting its effectiveness in modernizing the medical supplies industry and lowering healthcare costs for insurers and patients alike.

Eleos Health

Series B in 2023
Eleos Health develops innovative health technology solutions aimed at enhancing decision-making for clinicians in the behavioral health sector. The company's AI-powered Speech-to-Insights system operates during mental health sessions to analyze voice data in real time. By gathering insights on patients through this voice technology, Eleos Health enables clinicians to deliver personalized, efficient, and cost-effective care. The automated nature of the system helps streamline the clinical process, ultimately supporting mental health professionals in providing the necessary care and support for their patients.

Signos

Series B in 2023
Signos is focused on addressing the obesity epidemic by promoting healthy habits and stabilizing glucose levels through an innovative approach that combines continuous glucose monitoring with an AI-powered application. The company's platform offers real-time insights and personalized recommendations aimed at facilitating sustainable weight loss. By utilizing a wearable device alongside its software, Signos allows users to monitor their glucose levels and visualize their metabolism, empowering them to make informed dietary choices. With a significant portion of the American population facing challenges related to weight management, Signos provides a novel solution to help individuals understand their unique physiological responses to food, ultimately supporting their journey toward a healthier lifestyle.

Bold

Series A in 2023
Bold is an at-home digital fitness program designed to help older adults live their strongest, happiest, and healthiest lives. As a member, you’ll enjoy instant access to expert trainers, scientific assessments, and personalized workout plans to help you improve your strength, flexibility, and balance — so you can chase the life you want, at any age.

Pillyze

Series A in 2023
Pillyze develops a nutrition analysis platform designed to help individuals manage their intake of healthy functional foods and pharmaceuticals. The platform offers tools for analyzing, searching, and managing food options tailored to individual health needs, promoting healthier lifestyle choices. By focusing on the intersection of nutrition and wellness, Pillyze aims to empower users to make informed dietary decisions that support their overall health.

Affect Therapeutics

Series A in 2023
Affect Therapeutics operates a digital treatment platform designed to address drug and alcohol addiction through a mobile application. The company offers an integrated program for various substance use disorders, utilizing contingency management and reward systems to engage users and promote retention. By providing financial incentives, the platform encourages patients to adopt healthier behaviors and establish new habits, ultimately aiming to improve outcomes for individuals seeking to overcome addiction.

Calibrate

Convertible Note in 2022
Calibrate Health, Inc., established in 2020 and based in New York, specializes in digital metabolic health services. It offers a virtual program for sustainable weight loss, combining FDA-approved metabolic medications, a holistic curriculum, and one-on-one virtual coaching. The company's approach, designed by leading obesity and nutrition experts, targets the root causes of weight issues, aiming to improve metabolic health and drive lasting behavior change.

Malama

Pre Seed Round in 2022
Malama is a developer of a personalized support platform aimed at improving pregnancy-related health outcomes, particularly for individuals managing diabetes during pregnancy. The platform offers tools for tracking glucose levels and meal intake, helping users identify dietary triggers and trends. Additionally, it provides access to one-on-one coaching, facilitating the optimization of health throughout pregnancy. By delivering actionable insights, Malama empowers patients to enhance their health and well-being during this critical period.

Zen

Seed Round in 2021
Zen operates a digital ergonomic platform designed to enhance corporate ergonomic programs. The company focuses on providing ergonomic education and resources to employees, promoting healthy posture and productivity at work. Its offerings include real-time posture correction tools, exercise programs for back and joint care, and various ergonomic-related information. By empowering individuals to maintain better ergonomics, Zen aims to contribute to overall employee well-being and effectiveness in the workplace.

Agapé

Seed Round in 2021
Agapé is a relationship wellness platform founded in 2018 and based in Rochester, New York. The company focuses on fostering meaningful conversations between individuals through its innovative platform, which delivers daily questions aimed at enhancing emotional connections. By providing personalized advice and suggestions, Agapé assists couples in improving their relationships and deepening their understanding of one another. Its approach emphasizes the importance of communication and emotional well-being in nurturing successful partnerships.

Big Health

Series B in 2020
Big Health is a digital therapeutics company headquartered in London, United Kingdom, that specializes in developing and marketing innovative behavioral health programs. The company's flagship product, Sleepio, is a digital sleep improvement program that employs Cognitive Behavioral Therapy techniques to address and personalize sleep disorders. By offering a fully automated healthcare portal, Big Health delivers highly personalized digital therapeutics and behavioral programs aimed at tackling various mental health issues. Their approach combines medical consultation with user-friendly technology, enabling individuals to effectively manage and overcome sleep-related disorders in an efficient manner.

HealthifyMe

Series B in 2018
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

HealthifyMe

Series B in 2018
HealthifyMe is a fitness application designed to help users achieve their health and weight loss objectives through their computers and smartphones. Launched in 2012 by a team of doctors, nutritionists, and fitness trainers in Bangalore, India, the app allows users to track their calorie intake, monitor nutrition and fitness activities, and assess their weight to determine overall health. With features that enable users to set and work towards healthy goals, the platform also facilitates data sharing with experts, who provide personalized advice and recommendations. The application is enhanced by an artificial intelligence-powered fitness coach that leverages automated analytics, making it easier for users to receive tailored online fitness consultations and achieve their health aspirations.

Glooko

Series C in 2017
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Glooko

Series C in 2016
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Glooko

Series B in 2015
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.

Glooko

Series A in 2014
Glooko is a company that develops a remote patient-monitoring platform specifically designed for individuals with diabetes. This platform integrates with various diabetes devices, fitness wearables, and activity trackers to capture and sync health data. It provides comprehensive reports and analytics aimed at promoting behavior change and improving health outcomes. By enhancing communication between patients and healthcare providers, Glooko facilitates better management of diabetes and supports remote monitoring efforts. The platform is accessible on both Android and iOS devices, allowing users to conveniently track their diabetes-related information on their smartphones.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.